Our consulting team includes scientists with extensive pharmaceutical industry experience working for companies including Novartis, Sanofi, Merck and Bristol-Myers Squibb. PDDC scientists are highly knowledgeable in current methods of drug discovery research and, importantly, are well versed in key aspects of drug development and regulatory affairs. We have experts in medicinal chemistry, pharmacology, physical organic chemistry, pharmaceutics, and drug metabolism/PK/PD, safety, and toxicology. Via external expert networks, we include scientists in other fields as needed, to give client companies access to state of the art knowledge in drug discovery.

• CONSULTANT BIOGRAPHICAL INFORMATION
  • Edward Orton Ph.D.
  • Beverly Langevin Ph.D.
  • Scott Grossman Ph.D.
  • Alan Collis Ph.D.